This session will explore the practical use of hemoadsorption in critically ill patients with septic shock and severe AKI.
The case involves a patient with fecal peritonitis due to colon perforation who developed refractory postoperative septic shock despite surgical source control and broad-spectrum antibiotics. In the setting of high vasopressor requirement, elevated lactate, severe AKI, and markedly increased procalcitonin, CVVHDF with oXiris was initiated to target endotoxin and cytokine removal.
The expert discussion will focus on patient selection, timing of initiation, contraindications, technical optimization, anticoagulation and prevention of circuit clotting, cartridge change, monitoring response, criteria for stopping therapy, and when re-initiation should be considered.